2,027
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Biological therapy: chronicling 15 years of progress

 

Declaration of interest

In the past year, EM Lewiecki has received research grant support from Amgen, Eli Lilly and Merck. He has received consulting fees from Amgen, Eli Lilly, Merck, Radius Health, AgNovos Healthcare, Theranova, Alexion, NPS and AbbVie. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.